NIPT
Juno Diagnostics Ceases Commercial Operations
The prenatal testing firm had developed minimally invasive assays based on finger pricks instead of phlebotomy.
Prenetics, Dennis Lo Ink $200M Deal to Form Multi-Cancer Screening Firm
The joint venture plans to develop an epigenetics-based screening test for more than 10 types of cancers and launch sales of that test in 2027.
BGI Genomics Forges Partnerships for Precision Medicine in Latin America
Through the collaborations, the Chinese NGS service provider is introducing its oncology and noninvasive prenatal tests to Brazil, Argentina, and Chile.
Labcorp Ordered to Pay Ravgen Another $100M in Patent Lawsuit
Following its $272.5 million jury award last year, Ravgen secured enhanced damages for Labcorp's past violations of its prenatal testing patents.
Ravgen Prevails Over Streck in Patent Challenge
Streck is one of four firms that have challenged the validity of Ravgen's patent on noninvasive prenatal testing methods since Ravgen launched federal lawsuits alleging infringement.
Apr 17, 2023
Illumina, Ravgen Settle Patent Lawsuit Over NIPTs
Jan 25, 2023
Ravgen NIPT Patents Withstand Illumina Challenge
Dec 6, 2022
Cowen Upgrades PerkinElmer Stock to Outperform
Oct 20, 2022
Mar 30, 2022